Skip to main content
Premium Trial:

Request an Annual Quote

Forsyth, Kuwaiti Organizations Collaborate on Type 2 Diabetes Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Forsyth Institute today announced a research collaboration with the Dasman Diabetes Institute of Kuwait directed at type 2 diabetes in children.

The five-year agreement will also explore conditions that predispose children to obesity and research will be directed at maintaining metabolic health in children, Forsyth said in a statement. The Kuwait Dental School is also participating in the alliance.

Forsyth added that Kuwaiti scientists will largely manage the clinical research.

Financial terms of the partnership were not disclosed.

Scientists at Forsyth, based in Cambridge, Mass., will focus on discovering biomarkers in saliva that may indicate metabolic disease and the development of diabetes. A spokesperson for Forsyth said that the biomarkers being explored are proteins, metabolites, and oral microbes.

The Forsyth team is being led by J. Max Goodson, who is developing diagnostic tools suitable for the large-scale investigation of disease conditions in children that lead to diabetes.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.